The less-aggressive LNCaP and moderately aggressive PC3 prostate cancer cell lines showed variable loss of lamin B1 levels in nuclear blebs resulting in a bleb-to-body ratio of ∼0.75±0.04 (mean±s.e.m., Fig. 4D). This evidence concerns the gene LMNB1 and prostate cancer.